Merck & Co., Inc. (MRK)
NYSE · Manufacturing · Pharmaceutical preparations
$148.70+$0.7200 (+0.49%) on the dayAs of the close; data may be delayed.
MRK price, last 12 months
Key stats
- Previous close
- $147.98
- Open
- $147.96
- Day range
- $147.48 – $149.98
- 52-week range
- $77.58 – $156.92
- Volume
- 6.5M
- Avg volume (20 days)
- 9.8M
- Market cap
- $367.1B
Performance
1W+1.3%
1M−2.9%
3M+15.6%
6M+25.0%
YTD+41.3%
1Y+86.6%
vs S&P 500, 1Y+69.9 pts
Technicals and fundamentals
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $367.1B